ebomi
Colour theme
Sign in
Insider · CIK 0001565832

Traversa Sergio

CIK 0001565832 Name as filed on the most recent filing

Filed as Traversa Sergio (18)

51 transaction lines · from 18 filings · filed 2015-12-16 to 2025-12-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

51 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-12-15 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 27,500 acquired 4.12 113,300.00 Form 4, filing 0001213900-25-121974
2025-11-05 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 272,500 acquired 2.20 599,500.00 Form 4, filing 0001213900-25-106837
2025-08-28 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 55,976 acquired 0.74 41,422.24 Form 4, filing 0001213900-25-081837
2025-08-27 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 129,455 acquired 0.67 86,734.85 Form 4, filing 0001213900-25-081837
2025-08-26 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 80,545 acquired 0.62 49,937.90 Form 4, filing 0001213900-25-081837
2025-05-20 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 147,686 acquired 0.56 82,246.33 Form 4, filing 0001213900-25-046085
2025-05-19 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 30,000 acquired 0.50 14,994.00 Form 4, filing 0001213900-25-046085
2025-05-16 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 172,314 acquired 0.45 77,472.37 Form 4, filing 0001213900-25-046085
2024-09-11 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 51,407 acquired 2.99 153,706.93 Form 4, filing 0001213900-24-077795
2024-09-10 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 33,014 acquired 2.75 90,788.50 Form 4, filing 0001213900-24-077795
2024-09-09 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 55,579 acquired 2.71 150,619.09 Form 4, filing 0001213900-24-077795
2024-01-31 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 27,460 acquired 4.00 109,752.13 Form 4, filing 0001213900-24-008560
2024-01-30 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 40,999 acquired 3.90 159,949.40 Form 4, filing 0001213900-24-008560
2024-01-29 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 31,541 acquired 3.71 117,036.03 Form 4, filing 0001213900-24-008560
2022-12-08 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 55,250 acquired 2.10 115,804.00 Form 4, filing 0001213900-22-079244
2022-07-01 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 8,848 disposed 18.45 163,245.60 Form 4, filing 0001213900-22-037231
2022-07-01 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 4,068 disposed 18.32 74,525.76 Form 4, filing 0001213900-22-037231
2022-07-01 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 839 disposed 18.48 15,504.72 Form 4, filing 0001213900-22-037231
2022-06-30 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 10,698 disposed 19.01 203,368.98 Form 4, filing 0001213900-22-037231
2022-06-30 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 5,314 disposed 19.37 102,932.18 Form 4, filing 0001213900-22-037231
2021-03-10 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 2,983 disposed 35.09 104,675.86 Form 4, filing 0001213900-21-014918
2021-03-09 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 5,217 disposed 35.42 184,788.75 Form 4, filing 0001213900-21-014918
2021-03-09 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 1,800 disposed 36.32 65,380.32 Form 4, filing 0001213900-21-014918
2021-02-24 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 4,860 disposed 34.70 168,658.52 Form 4, filing 0001213900-21-012174
2021-02-24 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 4,837 disposed 33.69 162,962.88 Form 4, filing 0001213900-21-012174
2021-02-24 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 303 disposed 35.55 10,770.65 Form 4, filing 0001213900-21-012174
2021-02-11 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 1,446 disposed 35.43 51,238.43 Form 4, filing 0001213900-21-009699
2021-02-10 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 1,930 disposed 35.28 68,097.16 Form 4, filing 0001213900-21-008204
2021-02-09 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 5,963 disposed 35.21 209,938.74 Form 4, filing 0001213900-21-008204
2021-02-08 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 3,313 disposed 35.03 116,048.76 Form 4, filing 0001213900-21-008204
2021-02-03 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 100 disposed 35.00 3,500.00 Form 4, filing 0001213900-21-006834
2021-02-02 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 3,178 disposed 35.08 111,469.62 Form 4, filing 0001213900-21-006834
2021-01-27 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 5,549 disposed 32.86 182,340.14 Form 4, filing 0001213900-21-005448
2021-01-27 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 4,351 disposed 31.77 138,231.27 Form 4, filing 0001213900-21-005448
2021-01-27 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 100 disposed 33.43 3,343.00 Form 4, filing 0001213900-21-005448
2021-01-26 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 600 disposed 35.15 21,090.00 Form 4, filing 0001213900-21-004480
2021-01-25 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 1,300 disposed 35.29 45,877.00 Form 4, filing 0001213900-21-004480
2021-01-22 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 1,736 disposed 35.44 61,523.84 Form 4, filing 0001213900-21-004480
2021-01-22 Relmada Therapeutics, Inc.
RLMD 		S, Open-market sale 434 disposed 36.15 15,689.10 Form 4, filing 0001213900-21-004480
2016-04-15 Actinium Pharmaceuticals, Inc.
ATNM 		P, Open-market purchase 1,000 acquired 2.02 2,020.00 Form 4, filing 0001213900-16-012630
2016-04-14 Actinium Pharmaceuticals, Inc.
ATNM 		P, Open-market purchase 2,000 acquired 2.02 4,040.00 Form 4, filing 0001213900-16-012630
2015-12-15 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 5,600 acquired 2.91 16,296.00 Form 4, filing 0001213900-15-009534
2015-12-15 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 4,358 acquired 3.00 13,074.00 Form 4, filing 0001213900-15-009534
2015-12-15 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 2,759 acquired 2.99 8,249.41 Form 4, filing 0001213900-15-009534
2015-12-15 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 2,370 acquired 2.98 7,062.60 Form 4, filing 0001213900-15-009534
2015-12-15 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 1,800 acquired 3.42 6,156.00 Form 4, filing 0001213900-15-009534
2015-12-15 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 1,600 acquired 3.40 5,440.00 Form 4, filing 0001213900-15-009534
2015-12-15 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 241 acquired 2.92 703.72 Form 4, filing 0001213900-15-009534
2015-12-15 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 200 acquired 3.34 668.00 Form 4, filing 0001213900-15-009534
2015-12-15 Relmada Therapeutics, Inc.
RLMD 		P, Open-market purchase 42 acquired 3.39 142.38 Form 4, filing 0001213900-15-009534

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 27
  • Open-market sale 24
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. TRAVERSA SERGIO, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001565832

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.